Arcadia Biosciences (RKDA) Stock Statistics & Valuation Metrics

Arcadia Biosciences has a market cap or net worth of $2.67M. The enterprise value is $1.52M.

Arcadia Biosciences has 2,056,884 shares outstanding. The number of shares has decreased by -2.65% in one year.

Arcadia Biosciences’s return on equity (ROE) is -0.56 and return on invested capital (ROIC) is -222.75%.

The current PE Ratio of Arcadia Biosciences is ―. Arcadia Biosciences’s PEG ratio is 0.02.

In the last 12 months, Arcadia Biosciences had revenue of 4.86M and earned -2.34M in profits. Earnings per share was -1.71.

In the last 12 months, operating cash flow was -4.74M and capital expenditures 0.00, giving a free cash flow of -4.74M billion.

Arcadia Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Arcadia Biosciences upcoming earnings date is May 7, 2026, After Close (Confirmed).

Arcadia Biosciences as a current ratio of 3.09, with Debt / Equity ratio of 0.00%

In the past 12 months, Arcadia Biosciences has paid 8.00K in taxes.

Arcadia Biosciences EV to EBITDA ratio is -0.25, with an EV/FCF ratio of -0.52.

Arcadia Biosciences has $4.56M in cash and marketable securities with $0.00 in debt, giving a net cash position of $4.56M billion.

Gross margin is 36.21%, with operating margin of -205.74%, and net profit margin of -48.15%.

The average price target for Arcadia Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―